Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
Acta Eur Fertil
; 21(3): 139-41, 1990.
Article
en En
| MEDLINE
| ID: mdl-2149912
ABSTRACT
PIP: In order to evaluate the clinical and endocrinological efficacy of 2 low-dose oral contraceptives (OCs) containing 30 mcg ethinyl estradiol (EE) and 150 mcg desogestrel (DG) and 75 mcg gestodene (GD) respectively, an open randomized study was carried out on 34 young, hirsute women, matched for body mass index and age. All met endocrine and ultrasonic criteria for micropolycystic ovary syndrome (MPCO); participants were randomly assigned to 1 of 2 pill groups (n=17 each). The serum values for total testosterone (TT), free testosterone (FT), androstenedione (A), dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulphase (DHEAS), 17-hydroxyprogesterone (17Pg), sex hormone binding globulin (SHBG), ceruloplasmin (CP), as well as Ferriman-Gallway Index (FGI), and Free Androgen Index (FAI) were evaluated prior to and after EE-DG and EE-GD 6-cycle treatment. Significant decreases in TT, FT, A, 17PG, DHEA, DHEAS, FGI, and FAI were observed; SHBG and CP increased significantly. There were no significant differences between the 2 OCs. These results seem to indicate the both OCs are equally potent in pharmacological profile and residual androgenic activity. Therefore, these OCs may represent a highly effective and suitable alternative to the treatment of hyperandrogenism related to MPCO.
Palabras clave
Androgens; Biology; Clinical Research; Comparative Studies; Contraception; Contraceptive Agents, Estrogen--therapeutic use; Contraceptive Agents, Female--therapeutic use; Contraceptive Agents, Progestin--therapeutic use; Contraceptive Agents--therapeutic use; Contraceptive Methods--therapeutic use; Dehydroepiandrosterone--analysis; Desogestrel--therapeutic use; Developed Countries; Diseases; Endocrine System; Ethinyl Estradiol--therapeutic use; Europe; Examinations And Diagnoses; Family Planning; Gestodene--therapeutic use; Hirsutism; Hormones; Italy; Laboratory Examinations And Diagnoses; Mediterranean Countries; Oral Contraceptives, Low-dose--therapeutic use; Oral Contraceptives--therapeutic use; Physiology; Prospective Studies; Research Methodology; Signs And Symptoms; Southern Europe; Studies; Testosterone--analysis; Treatment
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Síndrome del Ovario Poliquístico
/
Anticonceptivos Hormonales Orales
/
Hirsutismo
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Acta Eur Fertil
Año:
1990
Tipo del documento:
Article
País de afiliación:
Italia
Pais de publicación:
Italia